Debatin KM - Search Results

1

TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB.

Ehrhardt H, Fulda S, Schmid I, Hiscott J, Debatin KM, Jeremias I. Ehrhardt H, et al. Among authors: debatin km. Oncogene. 2003 Jun 19;22(25):3842-52. doi: 10.1038/sj.onc.1206520. Oncogene. 2003. PMID: 12813457

2

Apoptosis pathways in neuroblastoma therapy.

Fulda S, Debatin KM. Fulda S, et al. Among authors: debatin km. Cancer Lett. 2003 Jul 18;197(1-2):131-5. doi: 10.1016/s0304-3835(03)00091-0. Cancer Lett. 2003. PMID: 12880972 Review.

3

[Impaired apoptosis regulation as cause for illness].

Jeremias I, Reinhardt D, Debatin KM. Jeremias I, et al. Among authors: debatin km. HNO. 2001 Aug;49(8):673-82; quiz 683, 685. doi: 10.1007/s001060170070. HNO. 2001. PMID: 11544893 German. No abstract available.

4

Trail (TNF-related apoptosis-inducing ligand) induces an inflammatory response in human adipocytes.

Zoller V, Funcke JB, Roos J, Dahlhaus M, Abd El Hay M, Holzmann K, Marienfeld R, Kietzmann T, Debatin KM, Wabitsch M, Fischer-Posovszky P. Zoller V, et al. Among authors: debatin km. Sci Rep. 2017 Jul 18;7(1):5691. doi: 10.1038/s41598-017-05932-7. Sci Rep. 2017. PMID: 28720906 Free PMC article.

5

Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML.

Meyer LH, Queudeville M, Eckhoff SM, Creutzig U, Reinhardt D, Karawajew L, Ludwig WD, Stahnke K, Debatin KM. Meyer LH, et al. Among authors: debatin km. Blood. 2008 Mar 1;111(5):2899-903. doi: 10.1182/blood-2007-08-109058. Epub 2007 Dec 14. Blood. 2008. PMID: 18083847

6

TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation.

Lehnert C, Weiswange M, Jeremias I, Bayer C, Grunert M, Debatin KM, Strauss G. Lehnert C, et al. Among authors: debatin km. J Immunol. 2014 Oct 15;193(8):4021-31. doi: 10.4049/jimmunol.1303242. Epub 2014 Sep 12. J Immunol. 2014. PMID: 25217163

7

γ-Secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets.

Dorneburg C, Goß AV, Fischer M, Roels F, Barth TF, Berthold F, Kappler R, Oswald F, Siveke JT, Molenaar JJ, Debatin KM, Beltinger C. Dorneburg C, et al. Among authors: debatin km. Oncotarget. 2016 Sep 27;7(39):62799-62813. doi: 10.18632/oncotarget.11715. Oncotarget. 2016. PMID: 27588497 Free PMC article.

8

Characterization of sonic hedgehog as a novel NF-kappaB target gene that promotes NF-kappaB-mediated apoptosis resistance and tumor growth in vivo.

Kasperczyk H, Baumann B, Debatin KM, Fulda S. Kasperczyk H, et al. Among authors: debatin km. FASEB J. 2009 Jan;23(1):21-33. doi: 10.1096/fj.08-111096. Epub 2008 Sep 4. FASEB J. 2009. PMID: 18772349

9

Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.

Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S. Vogler M, et al. Among authors: debatin km. Cancer Res. 2008 Oct 1;68(19):7956-65. doi: 10.1158/0008-5472.CAN-08-1296. Cancer Res. 2008. PMID: 18829553

10

Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway.

Naumann I, Kappler R, von Schweinitz D, Debatin KM, Fulda S. Naumann I, et al. Among authors: debatin km. Clin Cancer Res. 2011 May 15;17(10):3204-18. doi: 10.1158/1078-0432.CCR-10-2451. Epub 2011 Apr 1. Clin Cancer Res. 2011. PMID: 21459798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results